Subscriber access provided by Northern Illinois University
Article
6-Shogaol, an active constituent of dietary ginger, impairs cancer development and lung metastasis by inhibiting the secretion of CCL2 in tumor-associated dendritic cells Ya-Ling Hsu, Jen-Yu Hung, Ying-Ming Tsai, Eing-Mei Tsai, Ming-Shyan Huang, Ming-Feng Hou, and Po-Lin Kuo J. Agric. Food Chem., Just Accepted Manuscript • Publication Date (Web): 26 Jan 2015 Downloaded from http://pubs.acs.org on January 28, 2015
Just Accepted “Just Accepted” manuscripts have been peer-reviewed and accepted for publication. They are posted online prior to technical editing, formatting for publication and author proofing. The American Chemical Society provides “Just Accepted” as a free service to the research community to expedite the dissemination of scientific material as soon as possible after acceptance. “Just Accepted” manuscripts appear in full in PDF format accompanied by an HTML abstract. “Just Accepted” manuscripts have been fully peer reviewed, but should not be considered the official version of record. They are accessible to all readers and citable by the Digital Object Identifier (DOI®). “Just Accepted” is an optional service offered to authors. Therefore, the “Just Accepted” Web site may not include all articles that will be published in the journal. After a manuscript is technically edited and formatted, it will be removed from the “Just Accepted” Web site and published as an ASAP article. Note that technical editing may introduce minor changes to the manuscript text and/or graphics which could affect content, and all legal disclaimers and ethical guidelines that apply to the journal pertain. ACS cannot be held responsible for errors or consequences arising from the use of information contained in these “Just Accepted” manuscripts.
Journal of Agricultural and Food Chemistry is published by the American Chemical Society. 1155 Sixteenth Street N.W., Washington, DC 20036 Published by American Chemical Society. Copyright © American Chemical Society. However, no copyright claim is made to original U.S. Government works, or works produced by employees of any Commonwealth realm Crown government in the course of their duties.
Page 1 of 38
Journal of Agricultural and Food Chemistry
1
6-Shogaol, an active constituent of dietary ginger, impairs cancer
2
development and lung metastasis by inhibiting the secretion of CCL2
3
in tumor-associated dendritic cells
4 5
Ya-Ling Hsu,‡ Jen-Yu Hung,∫,# Ying-Ming Tsai,‡,# Eing-Mei Tsai,‡ Ming-Shyan
6
Huang,∫,# Ming-Feng Hou,† and Po-Lin Kuo†,§,¶,*
7 8
‡
Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University,
9 10
Kaohsiung 807, Taiwan ∫
School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung
11 12
807, Taiwan #
Division of Pulmonary and Critical Care Medicine, Kaohsiung Medical University
13 14
Hospital, Kaohsiung 807, Taiwan †
Institute of Clinical Medicine, College of Medicine, Kaohsiung Medical University,
15
Kaohsiung 807, Taiwan §
16
Research Center for Environmental Medicine, Kaohsiung Medical University,
17 18
Kaohsiung 807, Taiwan ¶
Institute of Medical Science and Technology, National Sun Yat-Sen University,
19
Kaohsiung 804, Taiwan
20 21
Corresponding Author
22
* Po-Lin Kuo, PhD. Institute of Clinical Medicine, College of Medicine, Kaohsiung
23
Medical University, No. 100, Shih-Chuan 1st Road, Kaohsiung 807, Taiwan. E-mail
24
address:
[email protected]; Phone: +886-7-312-1101 ext.2512 #33. Fax:
25
+886-7-321-0701
1
ACS Paragon Plus Environment
Journal of Agricultural and Food Chemistry
26
ABSTRACT
27
This study has two novel findings: it is not only the first to demonstrate that
28
tumor-associated dendritic cells (TADCs) facilitate lung and breast cancer metastasis
29
in vitro and in vivo by secreting inflammatory mediator CC-chemokine ligand 2
30
(CCL2), but it is also the first to reveal that 6-shogaol can decrease cancer
31
development and progression by inhibiting the production of TADC-derived CCL2.
32
Human lung cancer A549 and breast cancer MDA-MB-231 cells increase TADCs to
33
express high levels of CCL2, which increase cancer stem cell features, migration and
34
invasion, as well as immuno-suppressive tumor-associated macrophage infiltration.
35
6-Shogaol decreases cancer-induced up-regulation of CCL2 in TADCs, preventing the
36
enhancing effects of TADCs on tumorigenesis and metastatic properties in A549 and
37
MDA-MB-231 cells. A549 and MDA-MB-231 cells enhance CCL2 expression by
38
increasing the phosphorylation of signal transducer and activator of transcription 3
39
(STAT3), and the activation of STAT3 induced by A549 and MDA-MB-231 is
40
completed inhibited by 6-shogaol. 6-Shogaol also decreases the metastasis of lung and
41
breast cancers in mice. 6-Shogaol exerts significant anti-cancer effects on lung and
42
breast cells in vitro and in vivo by targeting the CCL2 secreted by TADCs. Thus,
43
6-shogaol may have the potential of being an efficacious immuno-therapeutic agent
44
for cancers. 2
ACS Paragon Plus Environment
Page 2 of 38
Page 3 of 38
Journal of Agricultural and Food Chemistry
45
KEYWORDS: 6-Shogaol; CCL2; lung cancer; breast cancer; metastasis
46
INTRODUCTION
47
The immune system plays the primary role of protecting the host against tumor
48
development
by
eliminating
pathogens/viral
infections,
timely
control
of
49
inflammation response, and removal of cancer cells expressing tumor-specific
50
antigens.1 However, the immune system may not always be sufficiently potent to
51
suppress the development of cancer. The dysfunction of dendritic cells (DC) induced
52
by cancer playa a major role in escaping immuno-surveillance.2,3 Cancer
53
cells produce soluble factors that impair immune cell development or function.4,5 In
54
turn, DCs co-exist in the tumor micro-environment and produce a multitude of soluble
55
factors and nutrients that promote tumor progression and growth.6,7 Understanding the
56
factors that contribute to this vicious cycle between tumor and tumor-associated DCs
57
(TADC) may help in the development of agents that will target these mediators as
58
new therapies for cancer treatment.
59
Chronic inflammation is an important tumor mediator and accelerator of many
60
malignancies. Elevated cytokine or chemokine levels in patients have been
61
increasingly correlated with poor prognosis.8,9 CC-chemokine ligand 2 (CCL2;
62
MCP-1) is a well-recognized inflammatory factor that can induce the migration of
63
monocytes, DCs, and T cells to sites of inflammation via the activation of CCR2.10-12 3
ACS Paragon Plus Environment
Journal of Agricultural and Food Chemistry
64
CCL2 expression in cancers is strongly associated with higher histologic grades and
65
acts as a biomarker for early relapse tumor-associated macrophages (TAM) and
66
monocyte infiltration.12 Moreover, CCL2 has been demonstrated to directly stimulate
67
cancer cell proliferation, survival, migration, and metastasis. Thus, it may play a role
68
in mediating cancer development via DC-cancer cell interaction.
69
Ginger (Zingiber officinale) is a well known plant used in cooking worldwide,
70
and has long been reputed to have medicinal properties. It is an herbaceous,
71
rhizomatous perennial plant widely distributed throughout tropical and subtropical
72
regions,13 and is cultivated on a large scale in Nigeria, India, Bangladesh, Sri Lanka,
73
Taiwan and other East Asian countries.13 Its biological constituents are
74
phenylpropanoid-derived compounds such as gingerols and shogaols, which possess
75
anti-cancer and anti-inflammatory activities, as has been reported in numerous
76
studies.14-19 The present study reveals that 6-shogaol inhibits TADCs’ role in the
77
switching of cancer stem cell-like phenotype, and enhancing cancer migration and
78
invasion by decreasing CCL2 secretion. These results suggest that 6-shogaol acts as
79
an effective therapeutic agent for cancer treatment by impeding the vicious cycle
80
between tumors and TADCs.
81
MATERIALS AND METHODS
82
Reagents and Antibodies. 6-Shogaol (6-SH) and 6-gingerol (6-GL) were purchased 4
ACS Paragon Plus Environment
Page 4 of 38
Page 5 of 38
Journal of Agricultural and Food Chemistry
83
from Sigma Chemicals Co (St. Louis, MO). Recombinant Human (rh) CCL2 protein
84
was obtained from R&D Systems (Minneapolis, MN).
85
Cell culture. Human breast cancer MDA-MB-231, lung cancer A549, mouse
86
mammary tumor 4T1, and Lewis lung carcinoma (LLC) cells were purchased from
87
American Type Culture Collection (ATCC) (Manassas, VA, USA).
88
MDA-MB-231 cells were cultured in Leibovitz's L-15 Medium supplemented with
89
10% fetal bovine serum (FBS), penicillin, and streptomycin in a CO2-free incubator.
90
The A549, 4T1 and LLC cells were cultured in F-12K Medium (Kaighn's
91
Modification of Ham's F-12 Medium) or RPMI1640 and DMEM containing 10% FBS
92
in a 5% CO2 incubator. For the conditioned medium (CM) collection, the
93
MDA-MB-231 and A549 cells (1Χ106) were seeded in a 10 cm dish and the
94
supernatants collected, filtered (0.22 mm), and defined as MDA-CM and A549-CM.
95
Isolation of CD14+ monocytes and differentiation of monocyte-derived DCs
96
(mdDCs). Monocytes were purified from peripheral blood mononuclear cells
97
(PBMCs) obtained from healthy consenting donors. Mononuclear cells were isolated
98
from the blood by the Ficoll-Hypaque gradient (GE Healthcare Bio-Sciences, Little
99
Chalfont, UK). CD14+ monocytes were purified using CD14+ monoclonal
100
antibody-conjugated magnetic beads (MACS MicroBeads, Miltenyi Biotec),
101
according to the manufacturer’s protocol. Monocyte-derived DCs (mdDCs) were 5
ACS Paragon Plus Environment
The
Journal of Agricultural and Food Chemistry
102
generated by culturing CD14+ monocytes in RPMI 1640 medium containing 10% FBS
103
(Invitrogen, Carlsbad, CA) and 20 ng/mL GM-CSF and 10 ng/mL IL-4 (R&D
104
Systems, Minneapolis, MN) with or without 6-SH (1 or 10 µM) for 5 days. The
105
medium was replaced with fresh medium containing GM-CSF and IL-4 on day 3. The
106
hospital’s Institutional Review Board approved the study and all of the patients
107
provided informed consent in accordance with the Declaration of Helsinki. A549 and
108
MDA-MB-231 tumor-associated mdDCs (A549-TADCs) and MDA-MB-231-TADCs
109
were generated by culturing CD14+ monocytes in RPMI 1640 medium containing
110
FBS, GM-CSF, and IL-4 presenting in A549-CM (20%) and MDA-MB-231-CM
111
(20%) with or without 6-SH (1 or 10 µM) for 5 days. After washing, the supernatants
112
were collected and frozen and stored at -80°C, and thawed singly for the study.
113
Measurement of Secreted Factors. Supernatants from mdDCs, A549-TADC,
114
MDA-TADCs, 6-shogaol-treated mdDC and TADC were collected. CD11c+F4/80-
115
cells were isolated from mice and cultured in RPMI1640 medium. After 24 h, the
116
supernatants were harvested. CXCL1, CCL2, and CCL4 levels were quantified using
117
human and mouse MILLIPLEX MAP kits.
118
Quantitative real-time PCR (qRT-PCR). Isolation of RNA was performed using the
119
TRIzol reagent (Invitrogen). cDNA was prepared using an oligo (dT) primer and
120
reverse transcriptase (Takara, Shiga, Japan) following standard protocols. Real-time 6
ACS Paragon Plus Environment
Page 6 of 38
Page 7 of 38
Journal of Agricultural and Food Chemistry
121
PCR was performed using SYBR Green on the ABI StepOnePlus™ real-time PCR
122
instrument (Applied Biosystems, Foster City, CA, USA). Each PCR reaction mixture
123
contained 100 nM of each primer, 5 µl of 2x SYBR Green PCR Master Mix (Applied
124
Biosystems, Foster City, CA), 2.5 µl of cDNA and RNase-free water for a total
125
volume of 10 µl. The PCR reaction was conducted with a denaturation step at 95°C
126
for 10 min, and then for 40 cycles at 95°C for 15 s, and 60°C for 1 min. All of the
127
PCRs
128
glyceraldehyde-3-phosphate dehydrogenase
129
expression was presented using the 2–△△CT method.
130
Tumor Spheroid Formation. A549 and MDA-MB-231 cells were labeled with
131
PKH67 (Sigma-Aldrich) following the manufacturer’s procedures. The cells were
132
seeded in ultra-low attachment wells with or without 6-shogaol pre-set conditioned
133
media (20%) of mdDCs or TADCs for tumor sphere formation. On day 10, the tumor
134
spheres were assessed by fluorescence microscopy, or dissociated into single cells for
135
ALDHFLOR analysis.
136
Flow Cytometry Analysis. Aldehyde dehydrogenases (ALDH) activity was assessed
137
using an ALDHFLOR kit (Stem Cell Technologies, Vancouver, BC, Canada). Briefly,
138
cells were incubated in Aldefluor assay buffer containing ALDH substrate
139
(1 µmol l−1 per 1 × 106cells), with or without diethylaminobenzaldehyde (DEAB), a
were
performed
in triplicate
and
normalized (GAPDH)
7
ACS Paragon Plus Environment
to
internal
mRNA.
The
control relative
Journal of Agricultural and Food Chemistry
140
specific ALDH inhibitor. After incubation at 37°C for 30 min, the cells were
141
centrifuged and re-suspended in cold Aldefluor buffer. ALDH activity was determined
142
by an Acuri C6 flow cytometer (Becton Dickinson Immuno-cytometry Systems). The
143
cells isolated from the lungs and mammary tumors of mice were stained by antibodies
144
against mouse CD11b labeled by FITC (BD Biosciences, San Jose, CA), F4/80
145
labeled by allophycocyanin (APC) (Biolegend). The expression of each molecule was
146
analyzed using an Acuri C6 flow cytometer (BD Biosciences).
147
Cell Migration and Invasion Analysis. Quantitative migration and invasion assay
148
was conducted using the QCM™ 24-well Cell Migration Assay and Invasion System
149
(Millipore Corp., Billerica, MA, USA). Briefly, 3 × 104 cells A549 or MDA-MB-231
150
cells were seeded into the top chamber, and CMs of mdDC, TADC, 6-shogaol-treated
151
mdDC and TADC were added to the bottom wells as chemo-attractant for 24 h (for
152
migration) or 48 h (for invasion). At the end of treatment, the cells were post-stained
153
with CyQuant GR dye in cell lysis buffer for 15 min at room temperature.
154
Fluorescence of the migratory or invaded cells was read using a fluorescence plate
155
reader at excitation and emission wavelengths of 485 and 540 nm, respectively.
156
Immunoblot Analysis. CD14+ monocytes (4×106) were pre-treated with 6-shogaol
157
for 1 h and the A549- or MDA-MB-231-CMs were added for 30 min. Total cell
158
extracts were prepared in RIPA lysis buffer (Millipore). Equivalent amounts of protein 8
ACS Paragon Plus Environment
Page 8 of 38
Page 9 of 38
Journal of Agricultural and Food Chemistry
159
were resolved by the SDS-PAGE and transferred to PVDF membranes. After the
160
membranes were blocked in Tris-buffer saline containing 0.05% Tween 20 (TBST)
161
and 5% non-fat powdered milk, they were incubated with primary antibodies against
162
p-STAT3, STAT3 and GAPDH (Cell Signaling Technology) at 4°C overnight. After
163
washing three times with TBST, the membranes were incubated with horseradish
164
peroxidase-labeled secondary antibody for 1 h and then re-washed. Detection was
165
performed using an enhanced chemiluminescence blotting detection system
166
(Millipore).
167
Chromatin Immuno-precipitation (ChIP). Chromatin immuno-precipitation (ChIP)
168
was conducted according to the protocol of the Pierce Agarose ChIP kit (Pierce,
169
Thermo Scientific, Rockford, IL). Immuno-precipitation conducted using anti-STAT3
170
transcription factors (Cell Signaling Technology) or by normal rabbit IgG (Cell
171
Signaling Technology) as the negative control. Input DNA and immuno-precipitated
172
DNA were analyzed by quantitative PCR. Primer sequences were obtained from
173
Qiagen (GPH1005667(-)01A).
174
Lung Metastasis of Lung and Breast Cancer In Vivo. Male C57BL and Female
175
BALB/c mice (5-6 wk old) from the National Science Council Animal Center (Taipei,
176
Taiwan) were maintained in pathogen-free conditions. 4T1 cells (2×106) were
177
implanted into mammary fat pads of BALB/c mice and LLC cells were implanted into 9
ACS Paragon Plus Environment
Journal of Agricultural and Food Chemistry
178
C57BL mice via tail vein injection. The mice were then randomly divided into two
179
groups: the 6-shogaol-treated group was given intra-peritoneal injection (ip) daily
180
with 0.2 ml of 6-shogaol (dose: 30 mg/kg of body weight) while the control group
181
was given an equal volume of normal saline. Tumor-bearing mice were sacrificed
182
14-21 days after transplantation. Lung (LLC bearing mice) and mammary tumors
183
(4T1 bearing mice) were collected and minced. Single cell suspensions were obtained
184
after enzymatic digestion (1 mg/ml collagenase A; Roche Diagnostics) and 100 IU/ml
185
type I DNase (Sigma-Aldrich) for 2 h at 37°C and 5% CO2 in RPMI 1640 medium.
186
Single cell suspension was filtered through a 70 µm nylon mesh (BD Biosciences)
187
and cells were washed twice by PBS. CD11c+ and CD11b+ cells were purified using
188
anti-CD11c or CD11b monoclonal antibody-conjugated magnetic beads (MACS
189
MicroBeads, Miltenyi Biotec). F4/80+ cells were depleted from CD11c+ cells by
190
using F4/80+ antibody-biotin beads (Miltenyi Biotec). Alternatively, the lungs were
191
removed and the metastatic tumor nodules counted. All animal experiments were
192
performed according to a protocol approved by the Institutional Animal Care and Use
193
Committee of Kaohsiung Medical University Hospital.
194
Statistical Analysis. Data were expressed as means ± SD. Statistical analyses
195
between control and experimental groups were analyzed by an unpaired
196
Student's t-test. Multiple comparisons were evaluated by a one-way ANOVA, and 10
ACS Paragon Plus Environment
Page 10 of 38
Page 11 of 38
Journal of Agricultural and Food Chemistry
197
differences in the mean values among groups were conducted by a Fischer post
198
hoc analysis. p values < 0.05 were considered to be statistically significant.
199
RESULTS
200
Lung cancer and breast cancer-derived TADCs secrete high levels of CCL2,
201
which are decreased by 6-shogaol and 6-gingerol. Previous studies and data show
202
that lung cancer A549 and breast cancer MDA-MB-231 cells increase the expression
203
of some inflammatory chemokines in TADCs.6 This study therefore assessed whether
204
the active components of ginger, 6-shogaol (6-SH) and 6-gingerol (6-GL), could
205
decrease the expression of these cytokines/chemokines in TADCs. The qRT-PCR data
206
demonstrated that A549- and MDA-MB-231-CMs (MDA-CM) increased levels of
207
CXCL1, CCL2, and CCL4 mRNA transcripts in TADC, when compared to mdDCs
208
(Figs. 1A and 1B). As determined by ELISA, the CMs of lung and breast cancers
209
increased the expression of CXCL1, CCL2, and CCL4 in protein levels in TADCs
210
(Fig. 1C to 1H). 6-Shogaol decreased the production of CCL2 in TADCs in protein
211
levels (Figs. 1E and 1F). The inhibitory effect of 6-shogaol on CCL2 secretion in
212
TADCs was greater than that of 6-gingerol. In addition, 6-shogaol decreased the
213
expression of CCL2 in TADCs in a dose-dependent manner ranging from 0.1-10 µM
214
(Figs 1I and 1J). Neither 6-shogaol nor 6-gingerol prevented the simulative effect of
215
cancers on the expression of CXCL1 and CCL4 in TADCs (Figs. 1C, 1D, 1F and 1G). 11
ACS Paragon Plus Environment
Journal of Agricultural and Food Chemistry
216
To eliminate the possibility of cytokines being reduced due to altered cell viability,
217
we assessed the effect of 6-shogaol and 6-gingerol (0.1-10 µM) on the cell viability of
218
TADCs. The data shows that 6-shogaol and 6-gingerol do not affect the viability of
219
TADCs (data not shown).
220
6-Shogaol decreases the effect of TADC-derived CCL2 on the formation of tumor
221
spheroids, migration and invasion. Because CCL2 has been reported to increase
222
cancer-stem cell like property and enhance cancer progression,20 this study assessed
223
the effect of 6-shogaol on the bio-activities of TADC-derived CCL2. The stem
224
cell-like phenotype is determined by tumor spheroid formation and aldehyde
225
dehydrogenases (ALDH) activity. A549- and MDA-MB-231-TADC-CM increased
226
tumor spheroid formation in A549 and MDA-MB-231 cell lines, respectively (Figs.
227
2A and 2B). However, TADCs lost their inductive effect on tumor spheroid formation
228
if they were generated in the presence of 6-shogaol (Figs. 2A and 2B). The
229
PKHhigh cells undergo fewer divisions during sphere formation, which implies they
230
possess a stem cell phenotype, in contrast to high proliferation non-stem PKHlow cells.
231
The ratio of PKHhigh cells increased in tumor spheroids cultured in TADC-CMs when
232
compared to those cultured in mdDC-CMs. 6-Shogaol treatment decreased the ratio of
233
PKHhigh cell population in tumor spheroids, revealing 6-shogaol reduces the stem cell
234
characteristics in both lung and breast cancers (Fig. 2A and 2B). Moreover, the 12
ACS Paragon Plus Environment
Page 12 of 38
Page 13 of 38
Journal of Agricultural and Food Chemistry
235
activity of ALDH, a stem cell marker, was enhanced in tumor spheroids cultured in
236
TADC-CMs when compared to those cultured in mdDC-CMs. However, the ALDH
237
activity of tumor spheroids was reduced when the TADCs were generated in the
238
presence of 6-shogaol (Fig. 2C and 2D). We next assessed the effect of 6-shogaol on
239
TADC-mediated cancer progression. A549- and MDA-MB-231-TADC-CM increased
240
A549 and MDA-MB-231 cell migration, respectively. However, TADCs lost their
241
inductive effect on cancer migration if they were generated in the presence of
242
6-shogaol (Figs. 3A and 3B). Similarly, A549- and MDA-MB-231-TADC-CM
243
increased cell invasion in A549 and MDA-MB-231 cells, but not if the TADC-CMs
244
were derived in the presence of 6-shogaol (Figs. 3C and 3D). In contrast, the addition
245
of rhCCL2 reduced the inhibitory effect of 6-shogaol on TADC-mediated A549 and
246
MDA-MB-231 cell migration (Fig. 3E and 3F).
247
6-Shogaol improves CCL2-mediated immuno-surveillance in lung and breast
248
cancers in vivo. Because CCL2 increases immuno-suppressive response by
249
decreasing macrophage infiltration in mice with cancer,20 this study assessed if
250
6-shogaol could alter immuno-surveillance in mice. LLC were transplanted into mice
251
by tail vein injection. The mice were sacrificed after 14 days, and TADC
252
(CD11c+F4/80-) cells from metastatic tumor nodules in the lungs were isolated and
253
examined. CCL2 expression in TADCs (CD11c+/F4/80-) of the lungs of mice with 13
ACS Paragon Plus Environment
Journal of Agricultural and Food Chemistry
254
LLC transplantation was higher than the dendritic cells isolated from the lungs of
255
normal mice. Administration of 6-shogaol decreased CCL2 levels in TADCs of the
256
lungs of mice with LLC transplantation (Fig. 4A). 6-Shogaol treatment also decreased
257
tumor associated macrophage (TAM) (CD11b+F4/80+) infiltration when compared to
258
vehicle-treated mice with LLC transplantation (Fig. 4B). To assess the effect of
259
6-shogaol on immuno-surveillance in breast cancer in vivo, 4T1 was implanted in the
260
mammary fat pads of mice. On day 14 post-tumor implantation, TAM and TADCs
261
were isolated from both mammary tissue and lungs with metastatic 4T1 tumors. 4T1
262
breast cancer cells also had increased CCL2 expression in TADCs when compared to
263
dendritic cells isolated from normal mammaries. This CCL2 up-regulation was
264
inhibited by 6-shogaol administration (Fig. 4C). Similarly, TAM infiltration also
265
decreased in 6-shogaol-treated mice (Fig. 4D).
266
6-Shogaol decreases CCL2 expression by inhibiting STAT3 activation in TADCs.
267
Since STAT3 was reported to bind to and activate the promoter of CCL2,20 this study
268
assessed if 6-shoagol could decrease the activation of STAT3. The CMs of lung
269
cancer A549 and breast cancer MDA-MB-231 cells increased the phosphorylation of
270
STAT3 in TADCs more than in mdDCs (Fig. 5A). The CMs of lung and breast cancers
271
also enhanced the nuclear translocation of activated STAT3 (Fig. 5B). These effects,
272
including STAT3 activation and nuclear translocation, were inhibited by 6-shogaol in 14
ACS Paragon Plus Environment
Page 14 of 38
Page 15 of 38
Journal of Agricultural and Food Chemistry
273
TADCs. ChIP analysis further revealed that CMs of A549 and MDA-MB-231 cancer
274
increased the binding of STAT3 on the promoter of CCL2 gene, but this was inhibited
275
by 6-shogaol treatment (Figs. 5C and 5D).
276
6-Shaogol decreases metastasis in lung and breast cancers in vivo. To assess the
277
activity of 6-shogaol on the metastasis of lung and breast cancers, LLC (by tail vein
278
injection) and 4T1 (by mammary fad pad implantation) were transplanted into mice,
279
which were sacrificed after 14 and 21 days, respectively. The tumors in the lungs of
280
mice were collected and counted. 6-Shogaol treatment decreased the number of LLC
281
tumor nodules in mice (Fig. 6A). Similarly, 6-shogaol also reduced the lung
282
metastasis of breast cancer 4T1 in mice (Fig. 6B).
283
DISCUSSION
284
Tumor micro-environment is characterized by a stroma of hematopoietic
285
precursors, inflammatory immune cells, dysregulated vessel endothelial cells, and
286
proteolytic enzymes.21,22 TADCs have been shown to lose their antigen-presenting
287
function, and also to promote cancer progression by modulating multiple components
288
in the cancer niche, thereby creating a permissive and supportive microenvironment
289
for tumor survival, proliferation, and spread.7,23,24 This study has two novel findings.
290
It is the first study to demonstrate that TADCs facilitate lung and breast cancer
291
metastasis in vitro and in vivo by secreting inflammatory mediator CCL2. It is also the 15
ACS Paragon Plus Environment
Journal of Agricultural and Food Chemistry
292
first study to demonstrate that 6-shogaol decreases cancer development and
293
progression by inhibiting the production of TADC-derived CCL2 (Fig. 7).
294
CCL2 has been implicated in cancer progression and metastasis. Serum CCL2
295
levels are significantly correlated to the cancer stage and have been shown to have
296
significant prognostic value for relapse-free survival.25-27 CCL2 appears to play a dual
297
role in regulating tumor immuno-surveillance and in sustaining the development and
298
advancement of established malignancy. CCL2 has also been implicated in directly
299
affecting cancers by switching the cancer stem cell-like phenotype and by enhancing
300
cancer cell survival, growth, angiogenesis, migration, and metastasis.28,29 It has also
301
been reported to indirectly facilitate carcinogenesis and metastasis by altering the
302
host’s immune response, including the accumulation of suppressive immune cells
303
TAM, MDSCs, and regulatory DC and T cells.20,30-32 CCL2 expression is modulated
304
in the interaction between tumor and niche cells, including fibroblasts and
305
adipocytes.20,30
306
This study demonstrates that cancer cells stimulate TADCs to express high levels
307
of CCL2, which in turn increase tumorigenesis by increasing cancer stem cell-like
308
properties. TADC-derived CCL2 also increases cancer migration and invasion; key
309
characteristics of metastatic cancer. However, these enhancing effects of TADCs on
310
cancer development are prevented by 6-shogaol treatment in vitro and in vivo. 16
ACS Paragon Plus Environment
Page 16 of 38
Page 17 of 38
Journal of Agricultural and Food Chemistry
311
6-shogaol administration decreases immuno-suppressive TAM infiltration in cancer,
312
suggesting that 6-shogaol may restore the host’s immune system.
313
Accumulating evidence supports a role for the STAT3 pathway in the
314
establishment of the inflammatory microenvironment. Constitutively activated STAT3
315
can drive various pro-tumorigenic and inflammatory mediator expressions in cancer
316
cells per se, as well as in niche cells.20,33,34 Breast cancer stimulates fibroblasts to
317
express high levels of CCL2 via a STAT3-dependent mechanism, resulting in
318
increased tumorigenesis. In contrast, inhibition of STAT3 in DCs enhances its ability
319
to prime T cells that have elevated IFNγ production,35 suggesting that STAT3 is a
320
potential target for developing a strategy that restores the host’s immunity against
321
tumors.
322
The results of this study reveal that cancer increases the activation and DNA
323
binding activity of STAT3, which in turn enhances the expression of CCL2 in TADCs.
324
6-Shogaol decreases the cancer-induced activation of STAT3, subsequently reducing
325
CCL2 levels in TADCs. According to the studies presented here, 6-shogaol may have
326
a novel mechanism for inhibiting STAT3 activation in TADCs, resulting in decreased
327
pro-tumorigenesis and inflammatory mediators in cancer niches.
328
In summary, this study provides novel insights for understanding the paracrine
329
interaction initiated by cancer cells to induce CCL2 production by TADCs. 17
ACS Paragon Plus Environment
Journal of Agricultural and Food Chemistry
Page 18 of 38
330
TADC-derived CCL2 promotes cancer progression by regulating cancer stem cell-like
331
properties, migration/invasion, and immuno-suppressive immune cell infiltration.
332
6-Shogaol has also been demonstrated to inhibit the effect of TADCs on cancer
333
tumorigenesis and progression by decreasing CCL2 production. 6-Shoagol also
334
reduces the accumulation of immuno-suppressive cells, suggesting that 6-shogaol may
335
serve as a future therapeutic agent for efficiently blocking the cancer-DC interaction
336
to overcome immune dysregulation and cancer progression.
337
Funding
338
This study was supported by grants from the National Science Council of Taiwan
339
(NSC
340
102-2628-B-037-002-MY3;
341
102-2314-B-037-035-MY3), the Ministry of Science and Technology (MOST
342
103-2320-B-037-006-MY3 and MOST 103-2314-B-037-052), the Excellence for
343
Cancer Research Center Grant, the Ministry of Health and Welfare, Executive Yuan,
344
Taipei, Taiwan (MOHW 103-TD-B-111-05), the Kaohsiung Medical University “Aim
345
for the Top 500 Universities Grant, Grant No. KMU-DT103008”, and the Kaohsiung
346
Medical
347
KMU-TP103A19 and KMU-TP103A20”.
348
Notes
101-2628-B-037-001-MY3;
University
“Aim
NSC
NSC
for
101-2320-B-037-043-MY3;
102-2632-B-037-001-MY3;
the
Top
Universities
18
ACS Paragon Plus Environment
Grant,
and
Grant
NSC NSC
Nos.
Page 19 of 38
Journal of Agricultural and Food Chemistry
349
The authors declare that there are no competing financial interests.
350
Acknowledgment
351
The authors also thank the Center for Resources, Research, and Development of
352
Kaohsiung Medical University for its support with the instrumentation.
353 354
REFERENCES
355
1.
356 357
Swann, J. B.; Smyth, M. J. Immune surveillance of tumors. J. Clin. Invest. 2007, 117, 1137-1146.
2.
Pinzon-Charry, A.; Maxwell, T.; López, J. A. Dendritic cell dysfunction in
358
cancer: a mechanism for immunosuppression. Immunol. Cell Biol. 2005, 83,
359
451-61
360
3.
Pyfferoen, L.; Mestdagh, P.; Vergote, K.; De Cabooter, N.; Vandesompele, J.;
361
Lambrecht, B. N.; Vermaelen, K. Y. Lung tumours reprogram pulmonary
362
dendritic cell immunogenicity at the microRNA level. Int. J. Cancer 2014, doi:
363
10.1002/ijc.28945.
364
4.
Obermajer, N.; Muthuswamy, R.; Lesnock, J.; Edwards, R. P.; Kalinski, P.
365
Positive feedback between PGE2 and COX2 redirects the differentiation of
366
human dendritic cells toward stable myeloid-derived suppressor cells. Blood
367
2011, 118, 5498-5505. 19
ACS Paragon Plus Environment
Journal of Agricultural and Food Chemistry
368
5.
Zhou, Z.; Li, W.; Song, Y.; Wang, L.; Zhang, K.; Yang, J.; Zhang, W.; Su, H.;
369
Zhang, Y. Growth differentiation factor-15 suppresses maturation and function
370
of dendritic cells and inhibits tumor-specific immune response. PLoS One 2013,
371
8, e78618.
372
6.
Kuo, P. L.; Huang, M. S.; Hung, J. Y.; Chou, S. H.; Chiang, S. Y.; Huang, Y. F.;
373
Yang, C. J.; Tsai, M. J.; Chang, W. A.; Hsu YL. Synergistic effect of lung
374
tumor-associated dendritic cell-derived HB-EGF and CXCL5 on cancer
375
progression. Int. J. Cancer 2014, 135, 96-108.
376
7.
Kuo, C. H.; Chen, K. F.; Chou, S. H.; Huang, Y. F.; Wu, C. Y.; Cheng, D. E.;
377
Chen, Y. W.; Yang, C. J.; Hung, J. Y.; Huang, M. S. Lung tumor-associated
378
dendritic cell-derived resistin promoted cancer progression by increasing
379
Wolf-Hirschhorn syndrome candidate 1/Twist pathway. Carcinogenesis 2013, 34,
380
2600-2609.
381
8.
Hansen, M. T.; Forst, B.; Cremers, N.; Quagliata, L.; Ambartsumian, N.;
382
Grum-Schwensen, B.; Klingelhöfer, J.; Abdul-Al, A.; Herrmann, P.; Osterland,
383
M.; Stein, U.; Nielsen, G. H.; Scherer, P. E.; Lukanidin, E.; Sleeman, J. P.;
384
Grigorian, M. A link between inflammation and metastasis: serum amyloid A1
385
and A3 induce metastasis, and are targets of metastasis-inducing S100A4.
386
Oncogene 2014, doi: 10.1038/onc.2013.568. 20
ACS Paragon Plus Environment
Page 20 of 38
Page 21 of 38
Journal of Agricultural and Food Chemistry
387
9.
Slattery, M. L.; John, E. M.; Torres-Mejia, G.; Lundgreen, A.; Herrick, J. S.;
388
Baumgartner, K. B.; Hines, L. M.; Stern, M. C.; Wolff, R. K. Genetic variation
389
in genes involved in hormones,inflammation and energetic factors and breast
390
cancer risk in an admixed population. Carcinogenesis 2012, 33, 1512-1521.
391
10. Kurihara, T.; Bravo, R. Cloning and functional expression of mCCR2, a murine
392
receptor for the C-C chemokines JE and FIC. J. Biol. Chem. 1996, 271,
393
11603-11607.
394
11. Chen, K.; Liu, M.; Liu, Y.; Wang, C.; Yoshimura, T.; Gong, W.; Le, Y.;
395
Tessarollo, L.; Wang, J. M. Signal relay by CC chemokine receptor 2 (CCR2)
396
and formylpeptide receptor 2(Fpr2) in the recruitment of monocyte-derived
397
dendritic cells in allergic airway inflammation. J. Biol. Chem. 2013, 288,
398
16262-16273.
399
12. Ueno, T,; Toi, M.; Saji, H.; Muta, M.; Bando, H.; Kuroi, K.; Koike, M.; Inadera,
400
H.; Matsushima, K. Significance of macrophage chemoattractant protein-1 in
401
macrophage recruitment, angiogenesis, and survival in human breast cancer. Clin.
402
Cancer Res. 2000, 6, 3282-3289.
403
13. Rahuman, A. A.; Gopalakrishnan, G.; Venkatesan, P.; Geetha, K.; Bagavan, A.
404
Mosquito larvicidal activity of isolated compounds from the rhizome of Zingiber
405
officinale. Phytother. Res. 2008, 22, 1035-1039. 21
ACS Paragon Plus Environment
Journal of Agricultural and Food Chemistry
406
14. Weng, C. J.; Chou, C. P.; Ho, C. T.; Yen, G. C. Molecular mechanism inhibiting
407
human hepatocarcinoma cell invasion by 6-shogaol and 6-gingerol. Mol. Nutr.
408
Food Res. 2012, 56, 1304-1314.
409
15. Weng, C. J.; Wu, C. F.; Huang, H. W.; Ho, C. T.; Yen, G. C. Anti-invasion effects
410
of 6-shogaol and 6-gingerol, two active components in ginger, on human
411
hepatocarcinoma cells. Mol. Nutr. Food Res. 2010, 54, 1618-1627.
412
16. Shieh, P. C.; Chen, Y. O.; Kuo, D. H.; Chen, F. A.; Tsai, M. L.; Chang, I. S.; Wu,
413
H.; Sang, S.; Ho, C. T.; Pan, M. H. Induction of apoptosis by [8]-shogaol via
414
reactive oxygen species generation, glutathione depletion, and caspase activation
415
in human leukemia cells. J. Agric Food Chem. 2010, 58, 3847-3854.
416
17. Sang, S.; Hong, J.; Wu, H.; Liu, J.; Yang, C. S.; Pan, M. H.; Badmaev, V.; Ho, C.
417
T.
Increased growth
inhibitory effects on
human cancer cells and
418
anti-inflammatory potency of shogaols from Zingiber officinale relative to
419
gingerols. J. Agric. Food Chem. 2009, 57, 10645-10650.
420
18. Pan, M. H.; Hsieh, M. C.; Hsu, P. C.; Ho, S. Y.; Lai, C. S.; Wu, H.; Sang, S.; Ho,
421
C. T. 6-Shogaol suppressed lipopolysaccharide-induced up-expression of iNOS
422
and COX-2 in murine macrophages. Mol. Nutr. Food Res. 2008, 52, 1467-1477.
423
19. Pan, M. H.; Hsieh, M. C.; Kuo, J. M.; Lai, C. S.; Wu, H.; Sang, S.; Ho, C. T.
424
6-Shogaol induces apoptosis in human colorectal carcinoma cells via ROS 22
ACS Paragon Plus Environment
Page 22 of 38
Page 23 of 38
Journal of Agricultural and Food Chemistry
425
production, caspase activation, and GADD 153 expression. Mol. Nutr. Food Res.
426
2008, 52, 527-537.
427
20. Tsuyada, A.; Chow, A.; Wu, J.; Somlo, G.; Chu, P.; Loera, S.; Luu, T.; Li, A. X.;
428
Wu, X.; Ye, W.; Chen, S.; Zhou, W.; Yu, Y.; Wang, Y. Z.; Ren, X.; Li, H.;
429
Scherle, P.; Kuroki, Y.; Wang, S. E. CCL2 mediates cross-talk between cancer
430
cells and stromal fibroblasts that regulates breast cancer stem cells. Cancer Res.
431
2012, 72, 2768-2779.
432
21. Xiang, T.; Long, H.; He, L.; Han, X.; Lin, K.; Liang, Z.; Zhuo, W.; Xie, R.; Zhu,
433
B. Interleukin-17 produced by tumor microenvironment promotes self-renewal
434
of CD133(+) cancer stem-like cells in ovarian cancer. Oncogene 2013,
435
doi:10.1038/onc.2013.537.
436
22. Louie, E.; Chen, X. F.; Coomes, A.; Ji, K.; Tsirka, S.; Chen, E. I. Neurotrophin-3
437
modulates breast cancer cells and the microenvironment to promote the growth
438
of breast cancer brain metastasis. Oncogene 2013, 32, 4064-4077.
439
23. Watkins, S. K.; Zhu, Z.; Riboldi, E.; Shafer-Weaver, K. A.; Stagliano, K. E.;
440
Sklavos, M. M.; Ambs, S.; Yagita, H.; Hurwitz, A. A. FOXO3 programs
441
tumor-associated DCs to become tolerogenic in human and murine prostate
442
cancer. J. Clin Invest. 2011, 121, 1361-1372.
443
24. Gottfried, E.; Kunz-Schughart, L. A.; Ebner, S.; Mueller-Klieser, W.; Hoves, S.; 23
ACS Paragon Plus Environment
Journal of Agricultural and Food Chemistry
444
Andreesen, R.; Mackensen, A.; Kreutz, M. Tumor-derived lactic acid modulates
445
dendritic cell activation and antigen expression. Blood 2006, 107, 2013-2021.
446
25. Wu, J.; Liu, X.; Wang, Y. Predictive value of preoperative serum CCL2, CCL18,
447 448 449
and VEGF for the patients with gastric cancer. BMC Clin. Pathol. 2013, 13, 15. 26. Steiner, J. L.; Murphy, E. A. Importance of chemokine (CC-motif) ligand 2 in breast cancer. Int. J. Biol. Markers. 2012, 27, e179-e185
450
27. Zhang, X. W.; Qin, X.; Qin, C. Y.; Yin, Y. L.; Chen, Y.; Zhu, H. L. Expression
451
of monocyte chemoattractant protein-1 and CC chemokine receptor 2 in
452
non-small cell lung cancer and its significance. Cancer Immunol. Immunother.
453
2013, 62, 563-570.
454
28. Li, X.; Xu, Q.; Wu, Y.; Li, J.; Tang, D.; Han, L.; Fan, Q. A CCL2/ROS
455
autoregulation loop is critical for cancer-associated fibroblasts-enhanced tumor
456
growth of oral squamous cell carcinoma. Carcinogenesis 2014, 35, 1362-1370.
457
29. Lin, T. H.; Liu, H. H.; Tsai, T. H.; Chen, C. C.; Hsieh, T. F.; Lee, S. S.; Lee, Y.
458
J.; Chen, W. C.; Tang, CH. CCL2 increases αvβ3 integrin expression and
459
subsequently promotes prostate cancer migration. Biochim. Biophys. Acta. 2013,
460
1830, 4917-4927.
461
30. Arendt, L. M.; McCready, J.; Keller, P. J.; Baker, D. D.; Naber, S. P.; Seewaldt,
462
V.; Kuperwasser, C. Obesity promotes breast cancer by CCL2-mediated 24
ACS Paragon Plus Environment
Page 24 of 38
Page 25 of 38
Journal of Agricultural and Food Chemistry
463
macrophage recruitment and angiogenesis. Cancer Res. 2013, 73, 6080-6093.
464
31. van Deventer, H. W.; Palmieri, D. A.; Wu, Q. P.; McCook, E. C.; Serody, J. S.
465
Circulating fibrocytes prepare the lung for cancer metastasis by recruiting
466
Ly-6C+ monocytes via CCL2. J. Immunol. 2013, 190, 4861-4867.
467
32. Kudo-Saito, C.; Shirako, H.; Ohike, M.; Tsukamoto, N.; Kawakami, Y. CCL2 is
468
critical for immunosuppression to promote cancer metastasis. Clin. Exp.
469
Metastasis 2013, 30, 393-405.
470
33. Fukuda, A.; Wang, S. C.; Morris, J. P 4th.; Folias, A. E.; Liou, A.; Kim, G. E.;
471
Akira, S.; Boucher, K. M.; Firpo, M. A.; Mulvihill, S. J.; Hebrok, M. Stat3 and
472
MMP7 contribute to pancreatic ductal adenocarcinoma initiation and progression.
473
Cancer Cell 2011, 19, 441-455
474
34. Vasquez-Dunddel, D.; Pan, F.; Zeng, Q.; Gorbounov, M.; Albesiano, E.; Fu, J.;
475
Blosser, R. L.; Tam, A. J.; Bruno, T.; Zhang, H.; Pardoll, D.; Kim, Y. STAT3
476
regulates arginase-I inmyeloid-derived suppressor cells from cancer patients. J.
477
Clin. Invest. 2013, 123, 1580-1589.
478
35. Sanseverino, I.; Purificato, C.; Varano, B.; Conti, L.; Gessani, S.; Gauzzi, M. C.
479
STAT3-silenced human dendritic cells have an enhanced ability to prime IFNγ
480
production by both αβ and γδ T lymphocytes. Immunobiology 2014, 219,
481
503-511.
482
25
ACS Paragon Plus Environment
Journal of Agricultural and Food Chemistry
483
FIGURE LEGENDS
484
Figure 1. 6-Shogaol and 6-gingerol decreased the expression of CCL2 in TADC.
485
The up-regulation of inflammatory chemokines in (A) A549- and (B)
486
MDA-MB-231-derived TADC, as determined by qRT-PCR. The active
487
components of ginger failed to inhibit the up-regulation of CXCL1 in both (C)
488
A549- and (D) MDA-MB-231-derived TADCs. 6-Shogaol (10 µM) and
489
6-gingerol (10 µM) decreased the expression of CCL2 in (E) A549- and (F)
490
MDA-MB-231-derived TADCs. 6-Shogaol (10 µM) and 6-gingerol (10 µM) did
491
not affect the stimulatory effect of (G) A549 and (H) MDA-MB-231 cells on
492
CCL4 expression of TADCs. 6-Shogaol decreased the expression of CCL2 in (I)
493
A549 and (J) MDA-MB-231-derived TADCs in a dose-dependent manner. The
494
expression of mRNA and protein was assessed by qRT-PCR and MILLIPLEX
495
MAP kits. All results are representative of at least three independent experiments,
496
and each value is the mean ± SD of three determinations. The results were
497
reported as mean ± SD; *p